Cargando…
Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
Tyro3, Axl, and Mertk (TAM) receptors are a subfamily of receptor tyrosine kinases. TAM receptors have been implicated in mediating efferocytosis, regulation of immune cells, secretion of inflammatory factors, and epithelial-to-mesenchymal transition in the tumor microenvironment, thereby serving as...
Autores principales: | Zhou, Yunxiang, Wang, Yali, Chen, Hailong, Xu, Yanyan, Luo, Yi, Deng, Yongchuan, Zhang, Jianmin, Shao, Anwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841914/ https://www.ncbi.nlm.nih.gov/pubmed/33509214 http://dx.doi.org/10.1186/s12964-020-00694-8 |
Ejemplares similares
-
Anesthesia and Oncology: Friend or Foe?
por: Buddeberg, Bigna S., et al.
Publicado: (2022) -
Medical Cannabis in Pediatric Oncology: Friend or Foe?
por: Malach, Megan, et al.
Publicado: (2022) -
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
por: Yao, Yihan, et al.
Publicado: (2020) -
Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020) -
The role and therapeutic potential of heat shock proteins in haemorrhagic stroke
por: Shao, Anwen, et al.
Publicado: (2019)